Despite these limitations, the results of first study were clear in showing that circulating cells from patients with Crohn’s disease exhibited significantly higher mean NLRC4-induced IL-1β and IL-18 responses than cells from control individuals. This evidence concerns the gene IL1B and Crohn disease.